Brignole M, Menozzi C, Lolli G, Sartore B, Barra M
Laboratory of Electrophysiology and Pacing, Hospital of Lavagna, Genoa, Italy.
Pacing Clin Electrophysiol. 1988 Nov;11(11 Pt 2):1628-35. doi: 10.1111/j.1540-8159.1988.tb06286.x.
Natural history of patients with symptomatic severe carotid sinus hypersensitivity is not clearly known. In order to evaluate the effectiveness of pacing therapy in these patients we performed a randomized treatment/no-treatment prospective study in 35 patients. They were randomly assigned to two groups: 19 patients received no therapy, 16 patients received a VVI (#11) or DDD (#5) pacemaker implant. During the 8.4 +/- 4.3 month follow-up period patients receiving no therapy had recurrence of syncope in 9 cases (47%) and minor symptoms in 13 (68%); at the 16th month, actuarial curve showed absence of syncope in 36% of patients and of any symptoms in 30%. During the 7.2 +/- 4.1 month follow-up period, the patients receiving the pacemaker implant had no recurrence of syncope, minor symptoms in three (19%); at the 16th month, actuarial curve showed absence of syncope in 100% of patients and of any symptoms in 78%. During follow-up, 12 patients in no-treatment group received a pacemaker implant because of the recurrence of severe symptoms; successively they had a strong reduction of symptoms. In conclusion, this study definitively demonstrates that patients with severe symptomatic carotid sinus hypersensitivity had a high rate of recurrence of spontaneous symptoms and that in these patients cardiac pacing is a useful therapy.
有症状的严重颈动脉窦过敏患者的自然病史尚不清楚。为了评估起搏治疗对这些患者的有效性,我们对35例患者进行了一项随机治疗/非治疗前瞻性研究。他们被随机分为两组:19例患者未接受治疗,16例患者接受了VVI(11例)或DDD(5例)起搏器植入。在8.4±4.3个月的随访期内,未接受治疗的患者中有9例(47%)晕厥复发,13例(68%)有轻微症状;在第16个月时,精算曲线显示36%的患者无晕厥,30%的患者无任何症状。在7.2±4.1个月的随访期内,接受起搏器植入的患者无晕厥复发,3例(19%)有轻微症状;在第16个月时,精算曲线显示100%的患者无晕厥,78%的患者无任何症状。随访期间,未治疗组有12例患者因严重症状复发接受了起搏器植入;随后他们的症状明显减轻。总之,这项研究明确表明,有症状的严重颈动脉窦过敏患者自发症状的复发率很高,并且在这些患者中,心脏起搏是一种有效的治疗方法。